CVS Health
CVS
1,550 hedge funds and large institutions have $53.3B invested in CVS Health in 2018 Q1 according to their latest regulatory filings, with 113 funds opening new positions, 630 increasing their positions, 666 reducing their positions, and 148 closing their positions.
24% more call options, than puts
Call options by funds: $821M | Put options by funds: $663M
5% more funds holding in top 10
Funds holding in top 10: 37 → 39 (+2)
0.29% more ownership
Funds ownership: 84.33% → 84.62% (+0.29%)
5% less repeat investments, than reductions
Existing positions increased: 630 | Existing positions reduced: 666
3% less funds holding
Funds holding: 1,599 → 1,550 (-49)
14% less capital invested
Capital invested by funds: $61.9B → $53.3B (-$8.51B)
24% less first-time investments, than exits
New positions opened: 113 | Existing positions closed: 148
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parnassus Investments
San Francisco,
California
|
+$653M |
| 2 |
JP Morgan Chase
New York
|
+$453M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$410M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$402M |
| 5 |
Harris Associates
Chicago,
Illinois
|
+$263M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$350M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$319M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$300M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$224M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$215M |
CVS Hedge Fund Activity: Q1 2018 in Review
1,550 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q1 2018, worth a combined $53.3B — down 14% from $61.9B a quarter earlier.
Sellers outnumbered buyers: 148 funds closed out of CVS and 113 opened new positions — a net loss of 35 holders — while 666 trimmed existing stakes and 630 added.
The largest buyer was Parnassus Investments, adding an estimated $653M. The largest seller was Arrowstreet Capital, cutting an estimated $350M.
- 1,550 institutional investors held CVS Health (CVS) as of Q1 2018, down from 1,599 in Q4 2017.
- Funds reported $53.3B of CVS Health stock for Q1 2018, down 14% quarter-over-quarter.
- 113 funds opened new CVS Health positions in Q1 2018 and 148 closed out, a net change of -35 holders.
- The largest CVS Health buyer in Q1 2018 was Parnassus Investments, an estimated $653M added.
- The largest CVS Health seller in Q1 2018 was Arrowstreet Capital, an estimated $350M sold.
Based on aggregated 13F filings for Q1 2018.